Aims

38
Aims Describe the activation of the complement cascade via: Classical pathway Alternative pathway Explain how activation of the complement cascade can impact other immunologic processes. Describe clinical implications of complement deficiencies. Readings: Abbas & Lichtman, Chapter 8

description

Aims. Describe the activation of the complement cascade via: Classical pathway Alternative pathway Explain how activation of the complement cascade can impact other immunologic processes. Describe clinical implications of complement deficiencies. Readings: Abbas & Lichtman, Chapter 8. - PowerPoint PPT Presentation

Transcript of Aims

Page 1: Aims

Aims

• Describe the activation of the complement cascade via:– Classical pathway

– Alternative pathway

• Explain how activation of the complement cascade can impact other immunologic processes.

• Describe clinical implications of complement deficiencies.

• Readings: Abbas & Lichtman, Chapter 8

Page 2: Aims

The Complement Activation Pathways

• There are three activation pathways – Classical - C1, C4, C2, C3– Alternate - properdin pathway– Mannose binding lectin or Lectin – uses MBL to

initiate the pathway

• All three activation pathways result in the formation of C3 & C5 convertases

• They converge at a single terminal pathway

Page 3: Aims

Classical Pathway

RBC

bacteria

EC

antibody

Page 4: Aims

Classical Pathway• C1 complex

– C1q has the antibody binding sites– C1r and C1s are serine proteases

C1-Inhibitor is released upon binding to Ab and this activates C1r & C1s.

Roitt’s Essential Immunology 2-2

Page 5: Aims

C1C1sC1r

C1q

Page 6: Aims

C1’C4a

C4b

Page 7: Aims

C1’

C4b

Page 8: Aims

C1’C2a

C2b

C4b

Page 9: Aims

C1’

C4b2b

C3 Convertase

a b

C3

Page 10: Aims

C1’

C4b2bC3a

C3b

Explosive amplification

Page 11: Aims

C1’

C5 Convertase

C4b2b3bba

C5

Page 12: Aims

C1’

C4b2b3bC5b

C5a

Page 13: Aims

C1’

C4b2b3b C5b

Page 14: Aims

C4b2b3b C5b

6 7

8

99 9 9

9999

K+Na+ and H2O

Membrane Attack Complex

Terminal Pathway

Page 15: Aims

Activators of the Alternative Complement Pathway

• Anything that hydrolyzes C3– leukocyte proteases– plasmin– bacteria or bacteral products (LPS, bacterial cell

wall components)– aggregated IgA– cobra venom factor– Cellophane– Water “Ticking over”

Page 16: Aims

Alternative Pathway

C3RBC

bacteria

EC

Page 17: Aims

Alternative Pathway

C3aRBC

bacteria

EC

C3b

Page 18: Aims

Alternative Pathway

RBC

bacteria

EC

C3bC3bC3b

Page 19: Aims

Alternative Pathway

bacterium

C3bbaFactor B

Factor D

Page 20: Aims

Alternative Pathway

bacterium

C3bBbBa

Page 21: Aims

Alternative Pathway

bacterium

C3bBb

Properdin

C3b

C3a

C3 Convertase

Page 22: Aims

Alternative Pathway

Roitt’s Essential Immunology 2-3

Page 23: Aims

Alternative Pathway

bacterium

C3bBb

Properdin

C3b

C3a

C3 binding and cleavage is repeated over and over (explosive amplification)

Page 24: Aims

Alternative Pathway

bacterium

Properdin

C3bnBb

C5 Convertase

Page 25: Aims

Alternative Pathway

bacteriumProperdin C3bnBb

C5 Convertase

C5b

C5a

Page 26: Aims

C5b

6 7

8

99 9 9

9999

K+Na+ and H2O

Membrane Attack Complex

C3bnBb

Terminal Pathway

Page 27: Aims

Terminal Pathway• Formation of

the MAC is identical in classical and alternative pathway once C5 convertase is formed.

Abbas & Lichtman’s Basic Immunology 8-6

Page 28: Aims

Lectin Pathway

RBC

bacteria

EC

MBL

Mannose Binding Lectin (MBL) binds terminal mannose residues of proteins and polysaccharides found on bacteria.

Page 29: Aims

MBL

Terminal Mannose residues

Only real difference from the classical pathway is that MBL is substituted for C1 complex during initiation.

Page 30: Aims

C1’

C4b2b3b C5b

Complement Pathway Regulation

• C3b by itself has a short half-life (s)

• C3b inactivator (Factor H, DAF, and Factor I)– Break apart stable structures and enzymatically cleave C3b

• C1 Inhibitor– Regulates classical pathway by dissociating C1r and C1s from C1q

– Can also regulate Lectin pathway by dissociating components of MBL

C5b6

7

8

9999

9999

Page 31: Aims

C1’

C4b2b3b C5b

Complement Pathway Regulation

• C4 binding protein– Breaks apart C4b2b (classical C3 convertase)

• Anaphylatoxin inactivator or serum carboxypeptidase B – Removes terminal arginine residue from C3a,C4a, and C5a.

• Vitronectin (S protein)– Serum protein which can bind C567 preventing complete MAC formation

C5b6

7

8

9999

9999

Page 32: Aims

Cells with Complement Receptors

ReceptorSpecificity Functions Cell typesCR1 C3b, C4b stimulates phagocytosis RBCs, M, PMN,

B cellsremoval of IC by RBCs

CR2 C3b, EBV B cell receptor complex B cellsEpstein-Barr virus receptor

CR3 C3b stimulates phagocytosis M, PMNs

CR4 C3b stimulates phagocytosis M, PMNs

C1q C1q binds IC to phagocytes B cells, M, platelets

endothelial cells

Page 33: Aims

Complement Deficiencies

• Deficiency of early cascade members (C1, C4, C2, and C3)– Deficiency in opsonization

• Poor phagocytosis resulting in increased infection with encapsulated bacteria.

• Poor clearance of IC associated with autoimmune diseases.

Page 34: Aims

Complement Deficiencies

Type I Hereditary angioedema – Stress and trauma provoked vasodilatation and

edema usually of the skin, extremities, or GI mucosa.

– Can be fatal if it involve larynx resulting in asphyxiation.

– Deficiency of C1INH• spontaneous generation of bradykinin• spontaneous activation of C1 C4a• production of C2a C2a kinin

Page 35: Aims

Complement Deficiencies

• Deficiency of late cascade members (C5, C6, C7, C8 and C9)– Deficiency in the formation of MAC– C5, C6, C7 or C8 deficiency results in difficulty

killing gram negative bacteria (Neisseria meningitidis)

Page 36: Aims

Summary

• Complement is a group of serum proteins – activated in an orderly fashion from inactive forms. This leads to “spin-off” peptides that have biological activity.

• Three main activation pathways and one terminal pathway that leads to the formation of the MAC.

• Complement activation is highly regulated.• Possession of complement component receptors lends

cells certain biological activities through interaction with complement.

• Deficiencies in complement components exist.

Page 37: Aims

Next Lecture

• Antigen capture and presentation

• Exogenous and Endogenous antigens.

• Readings: Abbas & Lichtman, Chapter 3

Page 38: Aims

Objectives

1. Describe the similarities and differences between the 3 complement cascade activation pathways.

1. Classical2. Alternative3. Lectin (Mannose Binding Lectin)

2. Describe complement regulation and deficiencies.